Johnson & Johnson Profit Margin 2006-2018 | JNJ

Current and historical gross margin, operating margin and net profit margin for Johnson & Johnson (JNJ) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Johnson & Johnson net profit margin as of December 31, 2018 is 18.75%.
Johnson & Johnson Annual Profit Margins
Johnson & Johnson Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $360.341B $81.581B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Pfizer (PFE) United States $249.842B 13.99
Merck (MRK) United States $212.837B 18.19
Novartis AG (NVS) Switzerland $205.636B 17.49
Eli Lilly (LLY) United States $127.913B 21.72
Novo Nordisk (NVO) Denmark $121.639B 19.68
AbbVie (ABBV) United States $121.119B 10.18
Sanofi (SNY) France $104.236B 12.87
GlaxoSmithKline (GSK) United Kingdom $101.357B 13.31
AstraZeneca (AZN) United Kingdom $101.265B 11.56
Bristol-Myers Squibb (BMY) United States $82.965B 12.77